Key facts
- This page summarizes John C. Reed's Form 4 filing for JOHNSON & JOHNSON (JNJ).
- 15 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 18 Feb 2026, 21:12.
John C. Reed - 15 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)
- Reporting relationship
- EVP, Innovative Medicine, R&D
- Issuer ticker
- JNJ
- Reported as of
- 15 Feb 2026
- Net transaction value
- -$5,224,221
- SEC form
- 4
- Accepted by SEC
- 18 Feb 2026, 21:12:02 UTC
- Prior SEC filing
- 20 Oct 2025
- Next SEC filing
- 04 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joleen Morgan, as attorney-in-fact for John C. Reed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John C. Reed filed Form 4 for JOHNSON & JOHNSON (JNJ) on 18 Feb 2026.
Change
- Previous filing in this sequence was filed on 20 Oct 2025.
- Current net transaction value: -$5,224,221.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001181561
Primary reporting owner
REED JOHN C
- Relationship
- EVP, Innovative Medicine, R&D
- Address
- ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
- Signature
- /s/ Joleen Morgan, as attorney-in-fact for John C. Reed
- Signature date
- 18 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JNJ
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,349
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 12,007
- Date
- 15 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
JNJ
transaction
Common Stock
Tax liability
- Transaction value
- $93,728
- Shares
- -385
- Change %
- -3.2%
- Price
- $243.45
- Shares after
- 11,622
- Date
- 15 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
JNJ
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,847
- Change %
- +16%
- Price
- $0.000000
- Shares after
- 13,469
- Date
- 15 Feb 2026
- Ownership
- Direct
- Footnotes
- F3
JNJ
transaction
Common Stock
Tax liability
- Transaction value
- $128,542
- Shares
- -528
- Change %
- -3.9%
- Price
- $243.45
- Shares after
- 12,941
- Date
- 15 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
JNJ
transaction
Common Stock
Options Exercise
- Transaction value
- $3,430,180
- Shares
- +21,721
- Change %
- +168%
- Price
- $157.92
- Shares after
- 34,662
- Date
- 17 Feb 2026
- Ownership
- Direct
JNJ
transaction
Common Stock
Sale
- Transaction value
- $5,278,203
- Shares
- -21,721
- Change %
- -63%
- Price
- $243.00
- Shares after
- 12,941
- Date
- 17 Feb 2026
- Ownership
- Direct
JNJ
transaction
Common Stock
Options Exercise
- Transaction value
- $4,673,101
- Shares
- +29,927
- Change %
- +231%
- Price
- $156.15
- Shares after
- 42,868
- Date
- 17 Feb 2026
- Ownership
- Direct
JNJ
transaction
Common Stock
Sale
- Transaction value
- $7,272,261
- Shares
- -29,927
- Change %
- -70%
- Price
- $243.00
- Shares after
- 12,941
- Date
- 17 Feb 2026
- Ownership
- Direct
JNJ
transaction
Common Stock
Sale
- Transaction value
- $554,769
- Shares
- -2,283
- Change %
- -18%
- Price
- $243.00
- Shares after
- 10,658
- Date
- 17 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JNJ
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,349
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 1,349
- Date
- 15 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,349
- Exercise price
- Footnotes
- F1, F4
JNJ
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,847
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 3,692
- Date
- 15 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,847
- Exercise price
- Footnotes
- F3, F4
JNJ
transaction
Derivative
Employee Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +49,382
- Change %
- Price
- $0.000000
- Shares after
- 49,382
- Date
- 15 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 49,382
- Exercise price
- $243.45
- Footnotes
- F5
JNJ
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +3,546
- Change %
- Price
- $0.000000
- Shares after
- 3,546
- Date
- 15 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,546
- Exercise price
- Footnotes
- F4, F6
JNJ
transaction
Derivative
Employee Stock Options (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -21,721
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 21,721
- Date
- 17 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,721
- Exercise price
- $157.92
- Footnotes
- F5
JNJ
transaction
Derivative
Employee Stock Options (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -29,927
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 59,854
- Date
- 17 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,927
- Exercise price
- $156.15
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
Footnote F2
Shares withheld for payment of taxes upon vesting of RSUs.
Footnote F3
Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
Footnote F4
Each RSU represents a contingent right to receive one share of Company Common Stock.
Footnote F5
Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F6
Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.